
XORTX Therapeutics Investor Relations Material
Latest events

Q1 2025
15 May, 2025

Q4 2024
26 Mar, 2025
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from XORTX Therapeutics Inc
Access all reports
XORTX Therapeutics Inc is a Canada-based clinical-stage biopharmaceutical company focused on developing therapies for chronic kidney disease and other health conditions related to abnormal purine metabolism and uric acid imbalance. The company’s lead drug candidates aim to lower serum uric acid levels to prevent or slow the progression of kidney and cardiovascular diseases. XORTX conducts research and clinical trials to advance its proprietary formulations. The company is headquartered in Calgary, Alberta, and its shares are listed on the NASDAQ.
Key slides for XORTX Therapeutics Inc


Investor Presentation
XORTX Therapeutics Inc


Investor Presentation
XORTX Therapeutics Inc
Latest articles
)
Airbnb: The Hospitality Giant Without Property
Airbnb has grown from an idea to help the Co-Founders make rent, to one of the most dominant companies in the global hospitality industry.
13 Jun 2025
)
MSCI: Indexing the World
The story of how MSCI has become the backbone of global finance through its indexes, powering decision-making across trillions in assets.
30 May 2025
)
A Purpose-Built AI Chat for Finance and IR Professionals
Quartr Pro's new AI chat lets IR and finance professionals ask anything across 13,000+ public companies and get instant answers.
27 May 2025
Ticker symbol
XRTX
Country
🇨🇦 Canada